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A corrigendum on 
Ionizing Particle Radiation as a Modulator of Endogenous Bone Marrow Cell Reprogramming: Implications for 
Hematological Cancers
by Muralidharan S, Sasi SP, Zuriaga MA, Hirschi KK, Porada CD, Coleman MA, et al. Front Oncol (2015) 5:231. doi: 10.3389/
fonc.2015.00231
In the paper titled “Ionizing Particle Radiation as a Modulator of Endogenous Bone Marrow Cell 
Reprogramming: Implications for Hematological Cancers,” there was secretarial error made at our 
end in “Figure 1,” which should be corrected. At some point of the submission in Figure 1, A and B 
were disarranged in the slide. No other correction is needed as the text and figure legends are correct.
FIGURE 1 | E-MPP and L-MPP cell numbers are downregulated by 56Fe- and 1H-IR but recover to control levels 
by 40 weeks post-IR. Effect of full-body single dose of proton (1H) at 0.5 Gy, 1 GeV and iron (56Fe) at 0.15 Gy, 1 GeV/
nucleon of ionizing radiation (IR) on survival of multipotent progenitor cell populations was examined. The survival of (A) 
E-MPPs and (B) L-MPPs in the BM after particle IR in C57BL/6NT mice were determined at 1, 2, 4, 8, 12, 28, and 
40 weeks post-IR. Total BM-derived mononuclear cells were triple-stained with FITC-labeled RAM34 antibody (that 
consists of CD34, c-kit, and Sca1 antibodies), PE-Cy7-AC133, and PE-hematopoietic lineage cocktail (CD3e, Ly-6G/
Ly-6C, CD11b, CD45R/B220, TER-119), then sorted by FASC for (A) E-MPPs (CD34+/c-kit+/Sca-1+/AC133+/Lin−) and (B) 
L-MPPs (CD34+/c-kit+/Sca-1+/AC133−/Lin−). Percentage changes in cell numbers were calculated relative to control sham 
irradiated mice, which was set to 100% for each time point. Solid lines represent mean ± SEM (n = 6/group) for 1H-IR (solid 
blue lines) and 56Fe-IR (solid red lines). “*” represents statistically significant differences compared to control with p < 0.05.
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